Spatial maps of hepatocellular carcinoma transcriptomes reveal spatial expression patterns in tumor immune microenvironment

肿瘤微环境 CCL19型 免疫系统 趋化因子 生物 癌症研究 肿瘤异质性 肝细胞癌 免疫学 癌症 趋化因子受体 遗传学
作者
Yue-fan Wang,Shengxian Yuan,Hui Jiang,Zhi‐Xuan Li,Hao-zan Yin,Jian Tan,Zhihui Dai,Chun-mei Ge,Shuhan Sun,Fu Yang
出处
期刊:Theranostics [Ivyspring International Publisher]
卷期号:12 (9): 4163-4180 被引量:38
标识
DOI:10.7150/thno.71873
摘要

Rationale: Hepatocellular carcinoma (HCC) is a highly heterogeneous and malignant disease with the complex immune microenvironment, which ultimately influence clinic outcomes of patients.However, the spatial expression patterns of diverse immune cells among tumor microenvironment remain to be further deciphered.Methods: Spatial transcriptomics sequencing (ST) was implemented on two portions of HCC specimens.Differentially expressed genes, cell cycle phases, epithelial-mesenchymal features, pseudo-time and immune infiltration analysis were applied to demonstrate the intratumor heterogeneity and define the specific immune-related regions, and the results were further validated by a second analysis on another ST study.In vitro and in vivo experiments were conducted to confirm the functional mechanisms of key molecules such as CCL15, CCL19 and CCL21.Clinical tissue samples were used to assess their potential prognostic and therapeutic values.Results: Totally, 7553 spots were categorized into 15 subsets by hierarchical clustering, and malignant subsets with intratumor heterogeneity phenotypes were identified.Spatial heterogeneity from distinct sectors highlights specific chemokines: CCL15 is remarkable in the core region of the carcinoma sector and facilitates the immunosuppressive microenvironment by recruiting and polarizing M2-like macrophages in vitro and in vivo; High expression of CCL15 and CD163 respectively predicts poor prognosis of HCC patients, and the combined application of them has better predictive value.CCL19 and CCL21, sharing similar spatial expression patterns, are highly-correlated and prominent in the immune infiltration enrichment and recruit CD3 + T cells and CD20 + B cells to inhibit the growth of HCC, indicating a good prognosis of HCC patients.Conclusions: Taken together, our studies preliminarily reveal intratumor heterogeneity of HCC based on ST techniques and unravel the previously unexplored spatial expression patterns in the immune microenvironment.We also highlight the clinical significance and spatial discrepancy of key molecules, providing novel insight for further developing therapeutic strategies in HCC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
111完成签到,获得积分10
1秒前
FashionBoy应助丽优采纳,获得10
2秒前
XCHEN完成签到,获得积分10
9秒前
紫陌完成签到,获得积分10
9秒前
FOX完成签到,获得积分10
10秒前
中科院的稻荷神完成签到,获得积分10
11秒前
阿泽完成签到,获得积分20
11秒前
15秒前
16秒前
小张吃不胖完成签到 ,获得积分10
17秒前
的法国队完成签到,获得积分10
18秒前
18秒前
yu完成签到 ,获得积分10
19秒前
20秒前
ZZ完成签到,获得积分10
21秒前
Kail发布了新的文献求助10
21秒前
研友_ZzaKqn完成签到,获得积分0
22秒前
22秒前
山神厘子完成签到,获得积分10
24秒前
C瓜菌完成签到,获得积分10
25秒前
25秒前
everglow发布了新的文献求助10
26秒前
27秒前
MR_芝欧完成签到,获得积分10
27秒前
丘比特应助weiwei采纳,获得10
28秒前
糊涂涂发布了新的文献求助10
30秒前
arui发布了新的文献求助10
30秒前
菘蓝完成签到 ,获得积分10
32秒前
C瓜菌发布了新的文献求助10
32秒前
33秒前
Akim应助zhou采纳,获得10
33秒前
34秒前
NexusExplorer应助胖头鱼采纳,获得10
34秒前
静槐完成签到,获得积分10
35秒前
35秒前
everglow完成签到,获得积分10
36秒前
okay完成签到,获得积分10
36秒前
LJ发布了新的文献求助10
39秒前
40秒前
dodder发布了新的文献求助10
40秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Various Faces of Animal Metaphor in English and Polish 800
Signals, Systems, and Signal Processing 610
Photodetectors: From Ultraviolet to Infrared 500
On the Dragon Seas, a sailor's adventures in the far east 500
Yangtze Reminiscences. Some Notes And Recollections Of Service With The China Navigation Company Ltd., 1925-1939 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6348748
求助须知:如何正确求助?哪些是违规求助? 8163942
关于积分的说明 17175597
捐赠科研通 5405356
什么是DOI,文献DOI怎么找? 2861984
邀请新用户注册赠送积分活动 1839714
关于科研通互助平台的介绍 1688977